{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:37:59Z","timestamp":1776317879963,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Oral and Dental Research Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Point of care testing (POCT) devices have been developed to facilitate immediate results with the potential to aid screening for new disease and enable patients to self-monitor their disease. Non-communicable diseases (NCDs) are the major cause of mortality globally and are increasing in prevalence as the population ages. Allied health care professionals (AHPs) are skilled in undertaking risk assessment and delivering preventative advice, providing opportunities to access large proportions of the population who may not visit their doctor, within non-traditional community settings. There is evidence of high levels of support from public, patients and health professionals for engaging AHPs in risk-targeted early case detection of certain NCDs. Thus, POCT devices offer a potential alternative to traditional venous blood collection, as novel care pathways for increasing early case detection and access to preventative care. The objectives of this study were to: (i) determine the concordance of the specific POCT devices with laboratory-based standard assays employed within clinical biochemistry laboratories. (ii) compare the sampling experience of both methods via patient-reported experiences.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A prospective, two-centre study was undertaken involving 158 participants who provided informed consent. Venous blood was collected for traditional assays of HbA1c, creatinine\/ estimated Glomerular-Filtration-Rate (eGFR) and vitamin-D. Capillary blood was collected by finger prick test and also assayed for the same biochemical indices (Nova StatSensor (creatinine\/eGFR); Siemens DCA-Vantage (HbA1C); CityAssays (vitamin-D)). All users were provided with device training. Participants reported any discomfort experienced by each simultaneously applied method (randomised in order) via a 100\u00a0mm Visual-Analogue-Scale.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Results for each POCT device and the laboratory standard were analysed by Bland-Altman plots to determine assay concordance. POCT devices demonstrated good concordance with laboratory testing, with at least 95% of all samples being within two standard deviations, for each of the devices tested. The majority of participants reported less discomfort with POCT than venepuncture, with the average reported discomfort being 17\/100\u00a0mm less for POCT compared to venous blood sample collection on the visual analogue scale.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The POCT devices demonstrated acceptable concordance with laboratory-based assays, and patients reported lower levels of discomfort compared to traditional means of blood collection. This study demonstrates the potential of using these devices as acceptable methods for opportunistic testing of \u201cat-risk\u201d individuals within non-traditional community care settings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-022-01999-z","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T08:04:15Z","timestamp":1663833855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Concordance of three point of care testing devices with clinical chemistry laboratory standard assays and patient-reported outcomes of blood sampling methods"],"prefix":"10.1186","volume":"22","author":[{"given":"Z.","family":"Yonel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kuningas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Jalal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cockwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Webber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Narendran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. L. C.","family":"Chapple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"key":"1999_CR1","unstructured":"Fact sheet on the SDGs: noncommunicable diseases. https:\/\/www.euro.who.int\/en\/health-topics\/noncommunicable-diseases"},{"issue":"1","key":"1999_CR2","doi-asserted-by":"publisher","first-page":"1532632","DOI":"10.1080\/16549716.2018.1532632","volume":"11","author":"K Wickramasinghe","year":"2018","unstructured":"Wickramasinghe K, Wilkins E, Foster C, Fadhil I, Hammerich A, Slama S, El Berri H, Elimam M, Adib S, Al-Mudwahi M, et al. The development of national multisectoral action plans for the prevention and control of noncommunicable diseases: experiences of national-level stakeholders in four countries. Glob Health Action. 2018;11(1):1532632\u20131532632.","journal-title":"Glob Health Action"},{"key":"1999_CR3","unstructured":"World Economic Forum HSoPH: The global economic burden of non-communicable diseases. In: 2011."},{"key":"1999_CR4","unstructured":"Cost of Non-Communicable Diseases in the EU. https:\/\/ec.europa.eu\/jrc\/en\/health-knowledge-gateway\/societal-impacts\/costs"},{"issue":"11","key":"1999_CR5","doi-asserted-by":"publisher","first-page":"e024503","DOI":"10.1136\/bmjopen-2018-024503","volume":"8","author":"Z Yonel","year":"2018","unstructured":"Yonel Z, Sharma P, Yahyouche A, Jalal Z, Dietrich T, Chapple IL. Patients\u2019 attendance patterns to different healthcare settings and perceptions of stakeholders regarding screening for chronic, non-communicable diseases in high street dental practices and community pharmacy: a cross-sectional study. BMJ Open. 2018;8(11):e024503.","journal-title":"BMJ Open"},{"key":"1999_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40496-020-00250-w","volume":"7","author":"Z Yonel","year":"2020","unstructured":"Yonel Z, Batt J, Jane R, Cerullo E, Gray LJ, Dietrich T, Chapple I. The role of the oral healthcare team in identification of type 2 diabetes mellitus: a systematic review. Curr Oral Health Rep. 2020;7:87\u201397. https:\/\/doi.org\/10.1007\/s40496-020-00250-w","journal-title":"Curr Oral Health Rep"},{"issue":"1","key":"1999_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.14219\/jada.archive.2010.0021","volume":"141","author":"BL Greenberg","year":"2010","unstructured":"Greenberg BL, Glick M, Julie FH, Kantor ML. Dentists\u2019 attitudes toward chairside screening for medical conditions. J Am Dent Assoc. 2010;141(1):52\u201362.","journal-title":"J Am Dent Assoc"},{"issue":"6","key":"1999_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0009-9120(00)00138-7","volume":"33","author":"P St-Louis","year":"2000","unstructured":"St-Louis P. Status of point-of-care testing: promise, realities, and possibilities. Clin Biochem. 2000;33(6):427\u201340.","journal-title":"Clin Biochem"},{"key":"1999_CR9","unstructured":"NICE Public Health Guidance [PH38] Type 2 diabetes: prevention in people at high risk. https:\/\/www.nice.org.uk\/guidance\/ph38\/chapter\/recommendations#recommendation-3-risk-identification-stage-1"},{"issue":"1","key":"1999_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.14219\/jada.2013.7","volume":"145","author":"RJ Genco","year":"2014","unstructured":"Genco RJ, Schifferle RE, Dunford RG, Falkner KL, Hsu WC, Balukjian J. Screening for diabetes mellitus in dental practices A field trial. J Am Dent Assoc. 2014;145(1):57\u201364.","journal-title":"J Am Dent Assoc"},{"issue":"3","key":"1999_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/jcpe.12358","volume":"42","author":"E Lalla","year":"2015","unstructured":"Lalla E, Cheng B, Kunzel C, Burkett S, Ferraro A, Lamster IB. Six-month outcomes in dental patients identified with hyperglycaemia: a randomized clinical trial. J Clin Periodontol. 2015;42(3):228\u201335.","journal-title":"J Clin Periodontol"},{"issue":"10","key":"1999_CR12","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1177\/0022034513502791","volume":"92","author":"E Lalla","year":"2013","unstructured":"Lalla E, Cheng B, Kunzel C, Burkett S, Lamster IB. Dental findings and identification of undiagnosed hyperglycemia. J Dent Res. 2013;92(10):888\u201392.","journal-title":"J Dent Res"},{"issue":"2","key":"1999_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/dme.12009","volume":"30","author":"S Engstrom","year":"2013","unstructured":"Engstrom S, Berne C, Gahnberg L, Svardsudd K. Effectiveness of screening for diabetes mellitus in dental health care. Diabet Med. 2013;30(2):239\u201345.","journal-title":"Diabet Med"},{"issue":"3","key":"1999_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/jphd.12082","volume":"75","author":"WH Herman","year":"2015","unstructured":"Herman WH, Taylor GW, Jacobson JJ, Burke R, Brown MB. Screening for prediabetes and type 2 diabetes in dental offices. J Public Health Dent. 2015;75(3):175\u201382.","journal-title":"J Public Health Dent"},{"issue":"5","key":"1999_CR15","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00784-012-0825-y","volume":"17","author":"A Barasch","year":"2013","unstructured":"Barasch A, Gilbert GH, Spurlock N, Funkhouser E, Persson LL, Safford MM, Group DC. Random plasma glucose values measured in community dental practices: findings from the dental practice-based research network. Clin Oral Investig. 2013;17(5):1383\u20138.","journal-title":"Clin Oral Investig"},{"issue":"2","key":"1999_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/idh.12140","volume":"14","author":"M Bossart","year":"2016","unstructured":"Bossart M, Calley KH, Gurenlian JR, Mason B, Ferguson RE, Peterson T. A pilot study of an HbA1c chairside screening protocol for diabetes in patients with chronic periodontitis: the dental hygienist\u2019s role. Int J Dental Hyg. 2016;14(2):98\u2013107.","journal-title":"Int J Dental Hyg"},{"key":"1999_CR17","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/dme.14324","volume":"37","author":"Z Yonel","year":"2020","unstructured":"Yonel Z, Cerullo E, Kr\u00f6ger AT, Gray LJ. Use of dental practices for the identification of adults with undiagnosed type 2 diabetes mellitus or non-diabetic hyperglycaemia: a systematic review. Diabet Med. 2020;37:1443\u201353. https:\/\/doi.org\/10.1111\/dme.14324.","journal-title":"Diabet Med"},{"key":"1999_CR18","unstructured":"Modernising NHS dentistry implementing the plan. Department of Health. Department of Health, editor. London: The Stationery Office; 2000."},{"key":"1999_CR19","unstructured":"NHS Dentistry: Options for Change. London: Department of Health, 2002. www.doh.gov.uk\/cdo\/optionsforchange"},{"key":"1999_CR20","unstructured":"The future of primary care: Creating teams for tomorrow, HEE Primary Care Workforce Commission; 2015."},{"key":"1999_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.annepidem.2020.06.004","volume":"48","author":"ES Rosenberg","year":"2020","unstructured":"Rosenberg ES, Tesoriero JM, Rosenthal EM, Chung R, Barranco MA, Styer LM, Parker MM, John Leung S-Y, Morne JE, Greene D, et al. Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York. Ann Epidemiol. 2020;48:23-29.e24.","journal-title":"Ann Epidemiol"},{"key":"1999_CR22","unstructured":"Public Health England NEaHEE: Making Every Contact Count. Department of Health. England: NHS England; 2016. https:\/\/www.hee.nhs.uk\/our-work\/population-health\/making-every-contact-count-mecc."},{"key":"1999_CR23","unstructured":"Smith J. PCaDM: Now more than ever: why pharmacy needs to act. Nuffield Trust. The Royal Pharmaceutical Society; (2014). https:\/\/www.nuffieldtrust.org.uk\/files\/2017-01\/now-more-than-ever-web-final.pdf."},{"key":"1999_CR24","unstructured":"National Health Service England: Five year forward view; 2014. https:\/\/www.england.nhs.uk\/wpcontent\/uploads\/2014\/10\/5yfv-web.pdf."},{"key":"1999_CR25","unstructured":"News Feature. Point-of-care testing in the community: a new role for pharmacists. Pharma J. 2001;20004868."},{"issue":"1","key":"1999_CR26","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1186\/s12889-020-09649-7","volume":"20","author":"Z Yonel","year":"2020","unstructured":"Yonel Z, Yahyouche A, Jalal Z, James A, Dietrich T, Chapple ILC. Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting. BMC Public Health. 2020;20(1):1576.","journal-title":"BMC Public Health"},{"issue":"6","key":"1999_CR27","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1345\/aph.1E504","volume":"39","author":"DA Sicard","year":"2005","unstructured":"Sicard DA, Taylor JR. Comparison of point-of-care HbA1c test versus standardized laboratory testing. Ann Pharmacother. 2005;39(6):1024\u20138.","journal-title":"Ann Pharmacother"},{"issue":"11","key":"1999_CR28","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.5858\/arpa.2011-0157-RA","volume":"135","author":"K Lewandrowski","year":"2011","unstructured":"Lewandrowski K, Gregory K, Macmillan D. Assuring quality in point-of-care testing: evolution of technologies, informatics, and program management. Arch Pathol Lab Med. 2011;135(11):1405\u201314.","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"1999_CR29","doi-asserted-by":"publisher","first-page":"e005611","DOI":"10.1136\/bmjopen-2014-005611","volume":"4","author":"J Howick","year":"2014","unstructured":"Howick J, Cals JW, Jones C, Price CP, Pluddemann A, Heneghan C, Berger MY, Buntinx F, Hickner J, Pace W, et al. Current and future use of point-of-care tests in primary care: an international survey in Australia, Belgium, The Netherlands, the UK and the USA. BMJ Open. 2014;4(8):e005611.","journal-title":"BMJ Open"},{"key":"1999_CR30","first-page":"A8210","volume":"158","author":"JW Cals","year":"2014","unstructured":"Cals JW, Schols AM, van Weert HC, Stevens F, Zeijen CG, Holtman G, Lucassen WA, Berger MY. Point-of-care testing in family practices: present use and need for tests in the future. Ned Tijdschr Geneeskd. 2014;158:A8210.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"6","key":"1999_CR31","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/j.1365-2141.2008.07274.x","volume":"142","author":"C Briggs","year":"2008","unstructured":"Briggs C, Guthrie D, Hyde K, Mackie I, Parker N, Popek M, Porter N, Stephens C. Guidelines for point-of-care testing: haematology. Br J Haematol. 2008;142(6):904\u201315.","journal-title":"Br J Haematol"},{"issue":"7","key":"1999_CR32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/j.1464-5491.2007.02175.x","volume":"24","author":"MA Stone","year":"2007","unstructured":"Stone MA, Burden AC, Burden M, Baker R, Khunti K. Near patient testing for glycated haemoglobin in people with Type 2 diabetes mellitus managed in primary care: acceptability and satisfaction. Diabet Med. 2007;24(7):792\u20135.","journal-title":"Diabet Med"},{"issue":"1","key":"1999_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/135581960000500109","volume":"5","author":"B Delaney","year":"2000","unstructured":"Delaney B, Wilson S, Fitzmaurice D, Hyde C, Hobbs R. Near-patient tests in primary care: setting the standards for evaluation. J Health Serv Res Policy. 2000;5(1):37\u201341.","journal-title":"J Health Serv Res Policy"},{"issue":"9","key":"1999_CR34","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/j.1365-2044.1976.tb11971.x","volume":"31","author":"SI Revill","year":"1976","unstructured":"Revill SI, Robinson JO, Rosen M, Hogg MI. The reliability of a linear analogue for evaluating pain. Anaesthesia. 1976;31(9):1191\u20138.","journal-title":"Anaesthesia"},{"issue":"2","key":"1999_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/096228029900800204","volume":"8","author":"JM Bland","year":"1999","unstructured":"Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135\u201360.","journal-title":"Stat Methods Med Res"},{"key":"1999_CR36","doi-asserted-by":"publisher","first-page":"f1630","DOI":"10.1136\/bmj.f1630","volume":"346","author":"P Sedgwick","year":"2013","unstructured":"Sedgwick P. Limits of agreement (Bland-Altman method). BMJ. 2013;346:f1630.","journal-title":"BMJ"},{"issue":"8","key":"1999_CR37","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1373\/clinchem.2014.224311","volume":"60","author":"E Lenters-Westra","year":"2014","unstructured":"Lenters-Westra E, Slingerland RJ. Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria. Clin Chem. 2014;60(8):1062\u201372.","journal-title":"Clin Chem"},{"issue":"2","key":"1999_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1515\/cclm-2016-0303","volume":"55","author":"JA Hirst","year":"2017","unstructured":"Hirst JA, McLellan JH, Price CP, English E, Feakins BG, Stevens RJ, Farmer AJ. Performance of point-of-care HbA1c test devices: implications for use in clinical practice - a systematic review and meta-analysis. Clin Chem Lab Med. 2017;55(2):167\u201380.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"1999_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10140-020-01829-7","volume":"28","author":"N Mathur","year":"2021","unstructured":"Mathur N, Lu ZX, MacKay L, Lau T, Kuganesan A, Lau KK. Is point of care renal function testing reliable screening pre-IV contrast administration? Emerg Radiol. 2021;28(1):77\u201382.","journal-title":"Emerg Radiol"},{"issue":"4","key":"1999_CR40","doi-asserted-by":"publisher","first-page":"e0122433","DOI":"10.1371\/journal.pone.0122433","volume":"10","author":"CS Kosack","year":"2015","unstructured":"Kosack CS, de Kieviet W, Bayrak K, Milovic A, Page AL. Evaluation of the Nova StatSensor\u00ae Xpress(TM) creatinine point-of-care handheld analyzer. PLoS One. 2015;10(4):e0122433.","journal-title":"PLoS One"},{"issue":"2","key":"1999_CR41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1017\/S0007114515004298","volume":"115","author":"U Hoeller","year":"2016","unstructured":"Hoeller U, Baur M, Roos FF, Brennan L, Daniel H, Fallaize R, Forster H, Gibney ER, Gibney M, Godlewska M, et al. Application of dried blood spots to determine vitamin D status in a large nutritional study with unsupervised sampling: the Food4Me project. Br J Nutr. 2016;115(2):202\u201311.","journal-title":"Br J Nutr"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-01999-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-022-01999-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-01999-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T08:06:28Z","timestamp":1663833988000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-022-01999-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1999"],"URL":"https:\/\/doi.org\/10.1186\/s12911-022-01999-z","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]},"assertion":[{"value":"17 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics committee approval was sought. Written consent for participation was obtained from all participants. All methods were carried out in accordance with relevant guidelines and regulations. South East Scotland Research Ethics Committee 1. REC reference: 16\/SS\/0197. Protocol number: RG_16-128. IRAS project ID: 212214.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Patients over 18\u00a0years of age with capacity were provided with a patient information leaflet (PIL), had the opportunity to read it prior to discussion with their healthcare professional, and prior to volunteering written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}